Riskpilot← Back to searchSign inGet full accessOlextra ApS
APSActiveCVR 42262137Industrivej 14Manufacture of prepared feeds for farm animals · NACE 1091Est. 202116 employeeswww.olextra.eu
Revenue 2025
DKK -24,6M
+141% vs 2024
EBITDA margin
130.8%
-187% vs 2024
Equity ratio
51.8%
Financial strength
Net profit 2025
DKK -36M
-165% vs 2024
| Revenue | DKK -24,6M | +141% |
| EBITDA | DKK -32,2M | -187% |
| Net profit | DKK -36M | -165% |
| Total assets | DKK 116,6M | +28% |
| Equity | DKK 60,4M | +64% |
| Employees | 16 | — |
Legal name
Olextra ApS
CVR number
42262137
Legal form
Anpartsselskab
NACE code
1091 · Manufacture of prepared feeds for farm animals
Founded
29. marts 2021
Share capital
DKK 73.334
Employees
16 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør og et bestyrelsesmedlem i forening eller den samlede bestyrelse.
Company purpose
Selskabets formål er at udvikle og implementere processer til produktion af fødevare- og foderingredienser baseret på restprodukter fra olivenolieproduktion, samt at producere og markedsføre sådanne ingredienser. Endvidere kan
Selskabet udstede licenser til tredjemand til produktion af disse ingredienser samt udøve virksomhed, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er blandt andet i sin virksomhed og drift at have en væsentlig positiv indvirkning på samfundet og miljøet som helhed.
Address
Industrivej 14
Phone
+4553765444
Email
info@olextra.eu
Website
www.olextra.eu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -2.261 | -4.776 | -4.908 | -10.238 | -24.625 |
| Staff expenses | -0 | -0 | -0 | -992 | -7.593 |
| EBITDA | -2.261 | -6.014 | -4.908 | -11.230 | -32.218 |
| Depreciation & amort. | -0 | -0 | -0 | -31 | -4.617 |
| EBIT | -2.261 | -6.014 | -4.908 | -11.260 | -36.835 |
| Net financials | -1 | -25 | -18 | -2.676 | -3.345 |
| Profit before tax | -2.262 | -6.039 | -4.926 | -13.936 | -40.180 |
| Tax | -0 | -0 | -0 | -381 | -4.195 |
| Net profit | -2.262 | -6.039 | -4.926 | -13.555 | -35.986 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 877 | 3.989 | 576 | 90.933 | 116.603 |
| Equity | 758 | 3.719 | -1.207 | 36.868 | 60.382 |
| Long-term debt | 0 | 0 | 0 | 45.125 | 44.117 |
| Short-term debt | 119 | 270 | 1.783 | 8.939 | 12.104 |
| Total debt | 119 | 270 | 1.783 | 54.064 | 56.220 |
EBITDA margin
-3221773900.0%
This company
15.8%
Market median
-20390974151% vs market
20212025
Equity ratio
51.8%
This company
38.2%
Market median
+36% vs market
20212025
Return on equity
-59.6%
This company
18.4%
Market median
-424% vs market
20212025
Net profit margin
-3598582900.0%
This company
8.1%
Market median
-44426949483% vs market
20212025
Asset turnover
-0.21×
This company
1.12×
Market median
-119% vs market
20212025
Debt / equity
0.93×
This company
0.62×
Market median
+50% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-03-29 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NW Management | Management | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Seneca Venture ApS | Company | 100.0% | 100.0% | 2023 |
Hommelhoff Group A/S | Company | 25.0% | 25.0% | 2021 |
Creari ApS | Company | 25.0% | 25.0% | 2023 |
OK BIOTECH ApS | Company | 33.3% | 33.3% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OK BIOTECH ApS
Olextra ApS Board members of Olextra ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nicolai Winding Andersen | Management | 0 companies |
| Lars Dahl Laursen | Board of Directors | 0 companies |
| Ole Kaae Hansen | Board of Directors | 0 companies |